Richard T. Arkwright III is a Ph.D. candidate in Wayne State University School of Medicine’s Cancer Biology graduate program

Richard T. Arkwright III is a Ph.D. candidate in Wayne State University School of Medicine’s Cancer Biology graduate program

Richard T. Arkwright III is a Ph.D. candidate in Wayne State University School of Medicine’s Cancer Biology graduate program in association with the Barbara Ann Karmanos Cancer Institute located in Detroit, MI. He is in the Department of Oncology under the mentorship of Dr. Q. Ping Dou. Richard obtained his B.S. degrees in Physiology and Human Biology from Michigan State University in 2008 where he worked at the National Superconducting Cyclotron Laboratory (NSCL) as a student operator and emergency medical technician. He then entered the Basic Medical Sciences graduate program (MS) at Wayne State University School of Medicine in 2008 during which time he worked in the laboratories of Drs. James Eliason and Carol Brenner, as a graduate research assistant working on non-viral induced pluripotent stem cells (IPSCs) reprogramming and the epigenetic characterization of human amniotic fluid cell-derived IPSCs. He then transferred into the Cancer Biology Ph.D. Program in 2011, where he currently studies the role of BCA2 in metformin resistance in breast cancer cells and the development of natural product-derived, targeted therapies.